MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Serum Zinc Deficiency could be associated with dementia conversion in Parkinson’s disease

    W. Jang (Gangneung, Republic of Korea)

    Objective: To investigate the role of depletion or excess of various heavy metals on clinical characteristics of Parkinson's disease (PD) developing PD dementia in drug-naïve…
  • 2023 International Congress

    Effect of levodopa on the interpretation of social interactions in people living with Parkinson’s disease

    T. Danaila, E. Metereau (Bron, France)

    Objective: Better understand the social interactions by assessing the effect of oral levodopa on the social cognition abilities in fluctuating PD patients without significant cognitive disorder.…
  • 2023 International Congress

    Adverse Events of Opicapone Adjunctive Therapy in 60 Consecutive Patients

    T. Bo, Y. Hashimoto, T. Ichikawa (Saitama, Japan)

    Objective: This study aimed to investigate the risk of adverse events (AEs) when opicapone (OPC) was added as adjunctive therapy to L-dopa administration. Background: Levodopa…
  • 2023 International Congress

    Evaluation of Cognitive Assessment Tools in Parkinson’s Disease

    L. Cao, Y. Huang (Beijing, China)

    Objective: To evaluate a variety of cognitive assessment scales in a longitudinal Parkinson’s disease (PD) cohort. Background: Cognitive impairment is one of the most common and…
  • 2023 International Congress

    Self-perception of symptoms lateralization and association with symptoms severity in Parkinson’s disease.

    V. Silva Costa, T. Figo Rocha, M. Oliveira Menacho, T. Silva Brito, A. Lepesteur Gianlorenço (São Carlos, Brazil)

    Objective: To compare the self-perception of symptoms lateralization with clinical evaluation, and explore associations with symptoms severity, onset side, and handedness. Background: Symptoms lateralization is…
  • 2023 International Congress

    Functional movement disorders in dopa-responsive dystonia – A case series with implications for diagnosis and treatment

    F. Hamami, J. Prasuhn, L. van Well, K. Lohmann, C. Klein, N. Brüggemann, T. Bäumer, A. Münchau, A. Weissbach (Lübeck, Germany)

    Objective: A detailed clinical characterization of functional movement disorders (FMD) in dopa-responsive dystonia (DRD) patients. Background: FMD are one of the most common conditions in…
  • 2023 International Congress

    Prognostic significance of peripheral neutrophils and lymphocytes in early Parkinson’s disease

    JS. Jun, R. Kim (Seoul, Republic of Korea)

    Objective: To explore whether peripheral blood neutrophils and lymphocytes are associated with longitudinal motor and cognitive decline in patients with early Parkinson’s disease (PD) and,…
  • 2023 International Congress

    Intercultural differences in patient and clinician perceptions of MDS-UPDRS in Parkinson’s disease

    V. Kaasinen, S. Luo, P. Martinez-Martin, C. Goetz, G. Stebbins (Turku, Finland)

    Objective: To explore culturally dependent differences between patient- and clinician-based evaluations of Parkinson’s disease (PD) motor symptoms. Background: Effects of multiple demographic factors on Movement…
  • 2023 International Congress

    Longitudinal brain volume decline in PD with RBD and olfactory dysfunction

    K. Kawabata, E. Bagarinao, K. Seppi, W. Poewe (Innsbruck, Austria)

    Objective: To elucidate longitudinal brain atrophies in PD with or without RBD and anosmia at baseline. Background: REM sleep behavior disorder (RBD) and olfactory dysfunction…
  • 2023 International Congress

    Stability of basal ganglia beta band power distribution during continuous deep brain stimulation in Parkinson’s disease: analysis of sub-cohort from the ADAPT-PD trial

    L. Hammer, E. Yilmaz, S. Little, H. Zahed, M. Volz, S. Ravi, S. Wang, P. Starr, J. Ostrem (San Francisco, USA)

    Objective: To assess the stability of the daily distribution of peak subthalamic nucleus (STN) and globus pallidus internus (GPi) beta band power during continuous deep…
  • « Previous Page
  • 1
  • …
  • 184
  • 185
  • 186
  • 187
  • 188
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • #25179 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley